Osaic Holdings’s AC Immune ACIU Stock Holding History

Osaic Holdings’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$607	Hold	221	–	–	﹤0.01%	7391
2025 Q4	$693	Sell	221 -30	-12%	-$95	﹤0.01%	7375
2025 Q3	$724	Hold	251	–	–	﹤0.01%	7455
2025 Q2	$509	Buy	+251	New	+$437	﹤0.01%	7345
2024 Q1	–	Sell	-2,000	Closed	-$10K	–	7187
2023 Q4	$10K	Hold	2,000	–	–	﹤0.01%	5830
2023 Q3	$5.7K	Hold	2,000	–	–	﹤0.01%	6211
2023 Q2	$5.91K	Hold	2,000	–	–	﹤0.01%	6229
2023 Q1	$4.68K	Hold	2,000	–	–	﹤0.01%	6354
2022 Q4	$4K	Hold	2,000	–	–	﹤0.01%	6364
2022 Q3	$6K	Sell	2,000 -1,000	-33%	-$3.15K	﹤0.01%	6250
2022 Q2	$11K	Sell	3,000 -100	-3%	-$342	﹤0.01%	5999
2022 Q1	$12K	Sell	3,100 -1,100	-26%	-$4.76K	﹤0.01%	6009
2021 Q4	$21K	Hold	4,200	–	–	﹤0.01%	5746
2021 Q3	$28K	Buy	4,200 +3,200	+320%	+$22.9K	﹤0.01%	5525
2021 Q2	$8K	Hold	1,000	–	–	﹤0.01%	6174
2021 Q1	$8K	Buy	+1,000	New	+$7.14K	﹤0.01%	5968

Other funds holding ACIU

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Osaic Holdings's ACIU Position: Q1 2026 in Review

Osaic Holdings held its AC Immune (ACIU) position steady in Q1 2026 at 221 shares worth $607. The position accounts for ﹤0.01% of the portfolio, ranked #7391.

Osaic Holdings first reported a position in ACIU in Q1 2021 and has held it in 16 quarters since. The position peaked at $28K in Q3 2021. 46 funds tracked by Wall St. Rank hold ACIU as of Q1 2026.

Osaic Holdings held 221 shares of AC Immune worth $607 as of Q1 2026.
Osaic Holdings left its AC Immune share count unchanged in Q1 2026.
AC Immune made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7391 holding.
Osaic Holdings first reported a position in AC Immune in Q1 2021 and has held it in 16 quarters since.
Osaic Holdings's AC Immune position peaked at $28K in Q3 2021.
46 funds tracked by Wall St. Rank held AC Immune as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.